pain syndrome News
-
XPhyto Files Patent Application for Library of Novel Psychedelic Compounds
XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to report that it has filed a patent application for a significant library of novel psychedelic compounds. Each compound was designed to provide specific alterations in their respective biopharmaceutical properties. The library of compounds can be selected to target ...
-
National Bladder Awareness Month: A Look at the Facts about Pelvic Radiation Cancer Survivors
Lipella Pharmaceuticals promotes awareness of hemorrhagic cystitis, a chronic painful syndrome that can be acquired by cancer patients who have received pelvic radiation therapy. PITTSBURGH, November 12, 2020 – During this November, Bladder Health Awareness Month, we promote the awareness of a serious bladder health condition, hemorrhagic cystitis, which affects many cancer survivors who ...
-
Creative Proteomics Launches Short-Chain Fatty Acid Analysis to Aid Gut Microbiota Research
With over 10 years of experience in advanced multi-omics services, Creative Proteomics has established a metabolomics platform dedicated to providing high-quality, personalized services, and reliable data to support global clients. With this metabolomics platform, the company was able to launch a new set of short-chain fatty acid analysis services. Short-chain fatty acids (SCFA) are organic ...
-
Confo Therapeutics Establishes Medical Advisory Board
Ghent, Belgium – June 10, 2021 – Confo Therapeutics today announced the establishment of its Medical Advisory Board (MAB). The MAB will provide external review and strategic advice for the company’s clinical development program including the future direction of CFTX-1554, Confo’s lead pre-clinical candidate in neuropathic pain. The international MAB members contribute ...
-
Treatment of Prostatitis - What Forms of Medicines Released?
Prostatitis is a disease characterized by the presence of inflammation and/or infection localized in the prostate gland. ...
-
Saluda Medical Receives FDA Approval for the Evoke® Spinal Cord Stimulation System to Treat Chronic Intractable Pain
Transformative closed-loop technology senses the spinal cord’s response to stimulation and instantaneously adjusts therapy to sustain durable, optimized treatment Long-term results published in two premier clinical journals show clinically meaningful improvements in pain relief, physical and emotional functioning, sleep quality, and health-related quality of life Saluda Medical Pty ...
-
Altoida Announces Partnership with Click Therapeutics to Power Clinical Trials with Digital Cognitive Assessment
Altoida, Inc. an artificial intelligence (AI) company pioneering next-generation neurological disease diagnostics, announced today a partnership with Click Therapeutics, a leader in Digital Therapeutics™ as prescription medical treatments, to bring more sensitive measures of cognition into their digital therapeutics research. The partnership will enable Altoida to power clinical trials for ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you